AmyHontMD

Pediatric Hematology & Oncology • Washington, DC

Physician

Join to view full profile

Dr. Hont is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hont's full profile

Already have an account?

Office
111 Michigan Avenue Northwest
Washington, DC 20010
Is this information wrong?

Education & Training

Children's National Medical Center/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2015 - 2018
University of Arizona College of Medicine-TucsonResidency, Pediatrics, 2012 - 2015
Ross University School of MedicineClass of 2012

Certifications & Licensure

MD State Medical License 2022 - 2024
DC State Medical License 2015 - 2024
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors Start of enrollment: 2021 Nov 17
Recruiting
Phase 1
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Successful treatment of disseminated mucormycosis in a pediatric patient with Wilms tumor.
Monica Gerber, Roma V Rajput, Amy B Hont> ;Pediatric Blood & Cancer. 2024 Feb 1
2 citations
The tumor microenvironment and immune targeting therapy in pediatric renal tumors.
Amy B Hont, Benoit Dumont, Kathryn S Sutton, John Anderson, Alex Kentsis, Jarno Drost, Andrew L Hong, Arnauld Verschuur> ;Pediatric Blood & Cancer. 2023 May 1
5 citations
Metformin for treatment of cytopenias in children and young adults with Fanconi anemia.
Jessica A Pollard, Elissa Furutani, Shanshan Liu, Erica Esrick, Laurie E Cohen, Jacob Bledsoe, Chih-Wei Liu, Kun Lu, Maria Jose Ramirez de Haro, Jordi Surrallés, Maggi...> ;Blood Advances. 2022 Jun 28
15 citations
The generation and application of antigen-specific T cell therapies for cancer and viral-associated disease.
Amy B Hont, Allison B Powell, Danielle K Sohai, Ashley E Geiger, Kajal Chaudhary, Ehsan Dowlati, Catherine M Bollard, Conrad Russell Y Cruz, Valdez, I., Stanojevic, M.> ;Molecular Therapy. 2022 Jun 1
1 citations
Using Molecular Stratification for Smart Combination Therapies.
Amy B. Hont, Catherine M. Bollard> ;Journal of Clinical Oncology. 2021 Sep 24
4 citations
Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell thera...
Maja Stanojevic, Amy B. Hont, Ashley Geiger, Samuel O'Brien, Robert Ulrey, Melanie Grant, Anushree Datar, Ping-Hsien Lee, Haili Lang, Conrad Russell Y. Cruz, Patrick J...> ;Cytotherapy. 2021 Apr 5
29 citations
Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study
Amy B. Hont, C. Russell Cruz, Robert Ulrey, Barbara O’Brien, Maja Stanojevic, Anushree Datar, Shuroug Albihani, Devin Saunders, Ryo Hanajiri, Karuna Panchapakesan, Sam...> ;Journal of Clinical Oncology. 2019 Jul 29
Join now to see all